Education
About Us
Working with TipRanks
Follow Us
Thiogenesis Therapeutics Corp (TSE:TTI)
:TTI
TTI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.50 - C$0.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)19.95K
Market Cap
C$25.11M
Enterprise ValueC$25.43M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.12
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding44,054,195
10 Day Avg. Volume34,100
30 Day Avg. Volume19,949
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Thiogenesis Therapeutics Corp News
PremiumCompany Announcements
Thiogenesis Expands European Reach with New Consultancy Agreement
PremiumCompany Announcements
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
PremiumCompany Announcements
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
PremiumCompany Announcements
Thiogenesis Therapeutics Advances in Mitochondrial Disease Trials
PremiumCompany Announcements
Thiogenesis Gains DTC Eligibility and Expands U.S. Presence
PremiumCompany Announcements
Thiogenesis Secures Key European Patent
PremiumCompany Announcements
Thiogenesis Boosts Investor Relations with New PartnershipPremiumCompany Announcements
Thiogenesis Discusses Breakthrough Treatment at Symposium---
Options Prices
Currently, No data available
---
Ownership Overview
15.37% Insiders
―
Mutual Funds
― Other Institutional Investors
84.63% Public Companies and
Individual Investors
TTI FAQ
What was Thiogenesis Therapeutics Corp’s price range in the past 12 months?
Thiogenesis Therapeutics Corp lowest stock price was C$0.50 and its highest was C$0.85 in the past 12 months.
What is Thiogenesis Therapeutics Corp’s market cap?
Thiogenesis Therapeutics Corp’s market cap is C$25.11M.
When is Thiogenesis Therapeutics Corp’s upcoming earnings report date?
Thiogenesis Therapeutics Corp’s upcoming earnings report date is May 07, 2025 which is in 45 days.
How were Thiogenesis Therapeutics Corp’s earnings last quarter?
Thiogenesis Therapeutics Corp released its earnings results on Nov 19, 2024. The company reported -C$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.014.
Is Thiogenesis Therapeutics Corp overvalued?
According to Wall Street analysts Thiogenesis Therapeutics Corp’s price is currently Overvalued.
Does Thiogenesis Therapeutics Corp pay dividends?
Thiogenesis Therapeutics Corp does not currently pay dividends.
What is Thiogenesis Therapeutics Corp’s EPS estimate?
Thiogenesis Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thiogenesis Therapeutics Corp have?
Thiogenesis Therapeutics Corp has 44,054,195 shares outstanding.
What happened to Thiogenesis Therapeutics Corp’s price movement after its last earnings report?
Thiogenesis Therapeutics Corp reported an EPS of -C$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.836%.
Which hedge fund is a major shareholder of Thiogenesis Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:TTI
---
Company Description
Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.
---
Technical Analysis
---